Mackenzie Financial Corp Amicus Therapeutics, Inc. Transaction History

Mackenzie Financial Corp

$66.8 Billion
Q3 2024

A detailed history of Mackenzie Financial Corp transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 28,877 shares of FOLD stock, worth $279,529. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,877

Previous 27,199 6.17%

Holding current value

$279,529

Previous $269,000 14.5%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$9.55 - $12.09 $16,024 - $20,287	1,678 Added 6.17%	28,877 $308,000
Q2 2024 Aug 14, 2024	BUY	$9.04 - $11.75 $1,726 - $2,244	191 Added 0.71%	27,199 $269,000
Q1 2024 May 10, 2024	SELL	$11.43 - $14.24 $23,420 - $29,177	-2,049 Reduced 7.05%	27,008 $318,000
Q4 2023 Jan 30, 2024	BUY	$9.97 - $14.52 $42,472 - $61,855	4,260 Added 17.18%	29,057 $412,000
Q3 2023 Oct 25, 2023	SELL	$11.78 - $13.86 $219,956 - $258,793	-18,672 Reduced 42.95%	24,797 $301,000
Q2 2023 Aug 03, 2023	SELL	$10.72 - $13.3 $82,661 - $102,556	-7,711 Reduced 15.07%	43,469 $545,000
Q1 2023 Apr 24, 2023	BUY	$10.91 - $13.54 $92,625 - $114,954	8,490 Added 19.89%	51,180 $567,000
Q4 2022 Feb 14, 2023	SELL	$9.89 - $12.7 $144,008 - $184,924	-14,561 Reduced 25.43%	42,690 $521,000
Q3 2022 Oct 07, 2022	SELL	$9.82 - $12.75 $209,912 - $272,544	-21,376 Reduced 27.19%	57,251 $598,000
Q2 2022 Aug 10, 2022	BUY	$6.23 - $11.12 $129,272 - $230,739	20,750 Added 35.85%	78,627 $844,000
Q1 2022 May 13, 2022	SELL	$7.89 - $12.48 $2,619 - $4,143	-332 Reduced 0.57%	57,877 $548,000
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $10,075 - $12,763	-1,026 Reduced 1.73%	58,209 $672,000
Q3 2021 Nov 08, 2021	BUY	$8.74 - $11.84 $56,923 - $77,113	6,513 Added 12.35%	59,235 $566,000
Q2 2021 Aug 11, 2021	BUY	$8.71 - $10.72 $139,760 - $172,013	16,046 Added 43.75%	52,722 $508,000
Q1 2021 May 14, 2021	BUY	$9.2 - $23.86 $157,366 - $408,125	17,105 Added 87.4%	36,676 $362,000
Q4 2020 Feb 10, 2021	SELL	$13.47 - $24.89 $534,947 - $988,481	-39,714 Reduced 66.99%	19,571 $452,000
Q3 2020 Nov 13, 2020	BUY	$12.89 - $15.89 $225,059 - $277,439	17,460 Added 41.75%	59,285 $837,000
Q2 2020 Aug 13, 2020	BUY	$8.86 - $15.69 $370,569 - $656,234	41,825 New	41,825 $630,000

Others Institutions Holding FOLD

# of Institutions

311

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.72B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Amicus Therapeutics, Inc. Transaction History